NEW YORK--(BUSINESS WIRE)--Scott + Scott, LLP, a global investor rights law firm, has opened an investigation on behalf of Stericycle depositary shareholders to determine whether Stericycle, Inc. (SRCLP) violated the federal securities laws by issuing materially misleading information to the investing public. To learn about the investigation, or to join the lawsuit, go to: http://www.scott-scott.com/pop.php?page=join&case_id=2746. There is no cost or obligation to you.
Stericycle provides regulated and compliance solutions to the healthcare and commercial businesses. Stericycle collects and processes specialized waste for disposal services. Stericycle’s regulated solutions include hazardous waste management, Steri-Safe medical waste and compliance programs, clinical services programs, Bio Systems reusable sharps containers, pharmaceutical waste disposal, medical safety products, and integrated waste stream solutions program.
On September 9, 2015, Stericycle announced the pricing of its public offering of 7,000,000 depositary shares, each of which represents a 1/10th interest in a share of its 5.25% Series A Mandatory Convertible Preferred Stock. The offering price was $100.00 per depositary share. On October 22, 2015, Stericycle reported its financial results for the 2015 third quarter. Addressing these results, Wedbush Equity Research stated that Stericycle’s Q3 revenue and Adjusted EPS of $718.6 million and $1.08 fell short of its estimates of $742.9 million and $1.19. On this news, shares of SRCLP fell more than 12%.
You can also call Joseph Halloran, Esq. at (646) 582-0121 or email email@example.com for information about the investigation.
Scott + Scott, LLP has significant experience in prosecuting major securities, antitrust, and employee retirement plan actions throughout the United States.